CRP and depressive symptom measurement: Future research could further elucidate how this pathway interacts with other systemic inflammation markers, such as the C-reactive protein to lymphocyte ratio (CLR), to deepen our understanding of the inflammatory underpinnings of depression and potentially guide new therapeutic interventions.